The National Health Museum: Exhibiting Influence on Tomorrow's Life Scientists

©John Horner According to results released last month of a widely administered ACT college entrance exam, only 26% of the graduating US high school seniors who took the test this year are adequately prepared for college biology. In other words, about one in four young adults are likely to muster a grade of C or higher in their freshman biology courses. It is further evidence that the United States is failing at a critical task. No easy explanation or quick remedy exists for this reality

Written byLouis Sullivan
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

According to results released last month of a widely administered ACT college entrance exam, only 26% of the graduating US high school seniors who took the test this year are adequately prepared for college biology. In other words, about one in four young adults are likely to muster a grade of C or higher in their freshman biology courses. It is further evidence that the United States is failing at a critical task.

No easy explanation or quick remedy exists for this reality. What is certain, though, is that we can and must do better. The United States has outstanding scientists, maintains the biggest investment of any nation to discover new knowledge, and has a vibrant, private research and development sector that is at the forefront of innovation of new medical devices, pharmaceuticals, and improved therapies. The global gains made in average life expectancy over the past century are owed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies